TTF1 and malignant mesothelioma: TTF-1 immunohistochemistry (IHC) is therefore routinely used in surgical pathology to support the difficult distinction of primary pulmonary adenocarcinomas which are often TTF-1 positive from malignant mesothelioma and metastatic adenocarcinoma to the lung which are usually TTF-1 negative [7].